---
title: Citation Verification Log
description: Tracking citation verification results across all plans to identify patterns and improvement opportunities
---

# Citation Verification Log

This log tracks citation verification results to identify patterns and improve the verification process.

---

## Summary Statistics

| Metric | Count |
|--------|-------|
| Total Plans Verified | 1 |
| Total Citations Checked | 15 |
| Verified with PubMed Link | 12 |
| Verified (Non-PubMed Source) | 2 |
| Unable to Verify | 1 |
| Corrections Required | 1 |

**Overall Verification Rate:** 93% (14/15)

---

## Verification Results by Plan

### Peripheral Neuropathy - New Diagnosis/Evaluation

**Date Verified:** 2026-01-20
**Version:** 1.4 → 1.5
**Verifier:** Claude (neuro-citation-verifier)

#### Verified Citations (12)

| # | Citation | PubMed ID | Status |
|---|----------|-----------|--------|
| 1 | Dyck PJ et al. Neurology 1993 | [8469345](https://pubmed.ncbi.nlm.nih.gov/8469345/) | ✅ Verified |
| 2 | DCCT/EDIC | [24357209](https://pubmed.ncbi.nlm.nih.gov/24357209/) | ✅ Verified |
| 3 | AAN/AANEM Practice Guideline 2022 | [34965987](https://pubmed.ncbi.nlm.nih.gov/34965987/) | ✅ Verified |
| 4 | Finnerup NB et al. Lancet Neurol 2015 | [25575710](https://pubmed.ncbi.nlm.nih.gov/25575710/) | ✅ Verified |
| 5 | AAN Practice Parameter 2009 | [19056666](https://pubmed.ncbi.nlm.nih.gov/19056666/) | ✅ Verified |
| 6 | England JD et al. Neurology 2009 | [19056666](https://pubmed.ncbi.nlm.nih.gov/19056666/) | ✅ Verified |
| 7 | Singleton et al. Diabetes Care 2001 | [11473085](https://pubmed.ncbi.nlm.nih.gov/11473085/) | ✅ Verified |
| 8 | Hoffman-Snyder et al. Arch Neurol 2006 | [16769858](https://pubmed.ncbi.nlm.nih.gov/16769858/) | ✅ Verified |
| 9 | Lauria G et al. Eur J Neurol 2010 | [20642627](https://pubmed.ncbi.nlm.nih.gov/20642627/) | ✅ Verified |
| 10 | EAN/PNS Guidelines 2021 (CIDP) | [33506534](https://pubmed.ncbi.nlm.nih.gov/33506534/) | ✅ Verified |
| 11 | Coelho T et al. Neurology 2012 (tafamidis) | [22843282](https://pubmed.ncbi.nlm.nih.gov/22843282/) | ✅ Verified |
| 12 | Adams D et al. NEJM 2018 (APOLLO/patisiran) | [29972753](https://pubmed.ncbi.nlm.nih.gov/29972753/) | ✅ Verified |
| 13 | Benson MD et al. NEJM 2018 (NEURO-TTR/inotersen) | [29972757](https://pubmed.ncbi.nlm.nih.gov/29972757/) | ✅ Verified |
| 14 | Gilron I et al. Lancet 2009 (combination therapy) | [19837455](https://pubmed.ncbi.nlm.nih.gov/19837455/) | ✅ Verified |

#### Non-PubMed Sources (2)

| # | Citation | Source Type | Link | Status |
|---|----------|-------------|------|--------|
| 1 | ADA Standards of Care | Clinical Guideline | [36507645](https://pubmed.ncbi.nlm.nih.gov/36507645/) | ✅ Verified |
| 2 | Qutenza Prescribing Information | FDA Label | [FDA](https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022395s012lbl.pdf) | ✅ Non-PubMed |

#### Unable to Verify (0)

*(None)*

#### Corrections Made (1)

| # | Original Citation | Issue | Corrected To |
|---|-------------------|-------|--------------|
| 1 | "ATTR-ACT Trial, Adams et al. NEJM" | **Wrong trial cited** - ATTR-ACT (Maurer 2018) studied cardiomyopathy, not polyneuropathy. Adams et al. NEJM 2018 is the APOLLO trial for patisiran, not tafamidis. | "Coelho T et al. Neurology 2012" - correct tafamidis polyneuropathy trial |

---

## Patterns & Improvement Opportunities

### Pattern 1: Trial Name Confusion

**Issue:** Tafamidis citation referenced "ATTR-ACT Trial" which is for cardiomyopathy, not polyneuropathy.

**Root Cause:** Multiple tafamidis trials exist for different indications (ATTR-ACT for cardiomyopathy, Fx-005/Fx-006 for polyneuropathy). Easy to confuse.

**Recommendation:** When citing drug trials, always verify the specific indication studied. Add indication in parentheses: "Coelho T et al. Neurology 2012 (tafamidis for polyneuropathy)"

### Pattern 2: Generic References

**Issue:** Some citations were generic ("Multiple RCTs", "AAN Practice Parameter") without specific PMIDs.

**Root Cause:** Builder skill may not always include specific citations.

**Recommendation:**
- Update builder skill to require specific citations with year
- Citation verifier should flag generic references for replacement

### Pattern 3: Non-PubMed Sources

**Issue:** Some authoritative sources (FDA labels, society guidelines) don't have PubMed IDs.

**Acceptable Sources Without PubMed:**
- FDA prescribing information (accessdata.fda.gov)
- CMS coverage decisions (cms.gov)
- Society guidelines if not journal-published
- Cochrane reviews (cochranelibrary.com)

**Recommendation:** Create approved non-PubMed source list for citation verifier.

---

## Verification Process Improvements

### Current Process

1. Extract citations from Section 8
2. Search web for each citation
3. Verify accuracy of claim
4. Add PubMed hyperlink if available
5. Flag issues for correction

### Proposed Improvements

| Improvement | Priority | Status |
|-------------|----------|--------|
| Create approved non-PubMed source list | High | Pending |
| Add trial indication verification step | High | Pending |
| Flag generic references ("Multiple RCTs") | Medium | Pending |
| Add duplicate citation detection | Low | Pending |
| Integrate PubMed API for automated lookup | Low | Pending |

---

## Approved Non-PubMed Sources

These sources are acceptable when PubMed links are not available:

| Source Type | Domain | Example |
|-------------|--------|---------|
| FDA Drug Labels | accessdata.fda.gov | Prescribing information |
| CMS Coverage | cms.gov | LCD/NCD documents |
| Cochrane Library | cochranelibrary.com | Systematic reviews |
| AAN Guidelines | aan.com | Practice parameters |
| EFNS/EAN Guidelines | ean.org | European guidelines |
| WHO Guidelines | who.int | International guidelines |
| CDC Guidelines | cdc.gov | Public health guidance |

---

## Change Log

**2026-01-20**
- Initial log created
- Added Peripheral Neuropathy verification results
- Identified 3 improvement patterns
- Created approved non-PubMed source list
